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A pntasialogangliosidc fraction of the ganglia series of glycosphingolipids has been isolated from human cerebellar cortex with a yield of 8.8 nmo! 
NeuAc per g fresh tissue. The structural analysis showed that the material was a mixture of GP! b and GPlc gangliosides. 
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1. INTRODUCTION doncerning structures of these new human brain 
gangliosides. 
Gangliosides constitute a heterogenous group of 
sialylated glycosphingolipids differing in both the 
oligosaccharide and ceramide composition. The majori- 
ty of brain gangliosides belong to a ganglio series of 
glycolipids and contain invariable tetrasaccharide 
backbones with variable numbers of sialic acid residues 
[1,2]. The most abundant human brain gangliosides are 
GDla, GDlb and GTlb, the most complex one describ- 
ed so far is GQlb. Gangliosides with more than 4 sialic 
acid residues per mol commonly occur in brains of some 
phylogenetically ower animals, e.g. fish [3], but not in 
the human brain. The presumable biological function 
of highly sialylated glycosphingolipids includes the par- 
ticipation in developmental processes [4-61 and in con- 
ductance of signals in nervous cells [7,8]. Findings con- 
cerning cholinergic-specific oligosialogangliosides 
Chol-I [8,9] are of great interest. 
In a next paper (H. Miller-Podraza et al., in prepara- 
tion) we will report on chromatographic evidence for 
the presence in the human brain of low quantities of 
highly sialylated ganglioside fractions migrating on 
thin-layer plates below ganglioside GQlb. We also 
showed that the cerebcllar cortex was a good source of 
pentasialogangliosides. In this paper we report data 
2. EXPERIMENTAL 
2. I . Maieriais 
Human cerebellar tissue was obtained from the Department of 
Forensic Medicine, University of Giiteborg. The cerebellar cortex was 
dissected from organs in our laboratory. Silica gel 60, 230-400 mesh 
and glass-backed HPTLC plates of silica gel 60 were from Merck, 
Darmstadt (Germany). Sephadcx G-25 (fine) was from Pharmacia, 
Uppsala (Sweden). Standard human brain (GM3-GQlb) and fish 
brain (GPl) gangliasides were isolated and characterized in our 
laboratory. All organic solvents used were of HPLC quality. A!! other 
chemicals used were of analytical quality and used without further 
purification. 
2.2. Isolation of pentasialogangliosides 
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(Eur. J. Biochem. (1977) 79, 11-21). GPI, pentasialoganglioside; 
GPlb. IV’(NeuAc),ll’(NeuAc)2GgOse~Cer; BPls, IV’(NeuAc)z!13- 
(NeuA)3GgOse.+Cer. 
The cerebellar cortex (400 g) was homogenized in I vol. of water in 
a scissors homogenizer. Methanol and chloroform were added to 
make the final proportions of chloroform/methanol/water, 8:4:3 
(v/v), and the tissue was extracted uring stirring for 2 h. The mixture 
was centrifuged and the pellet was re-extracted once in 4 I of the same 
solvent system under the same conditions. The combined super- 
natants were evaporated and the material was divided into 2 parts, 
which were processed separately under the same conditions. Complex 
gangliosides were isolated from the crude lipids according to the 
method described in a forthcoming paper (H. Miller-Pcdraza et a!., 
in preparation). Briefly: the matcria! (corresponding to 200 g of the 
fresh tissue) was dissolved in 300 ml of chloroform/methanol/water, 
65:25:4 (v/v), and applied to a column of 150 g of silica gel (silica gel 
packed in chloroform/methanol, 4: I, v/v). The column was eluted 
with: (I) c!~!oroform/methano!/water, 65:25:4 (v/v), 600 ml; (2) 
ch!oroform/methano!/0.25~o KCI in 2.5 M ammonia, 50:4O:lO(v/v). 
300 ml; (3) propano!/water, 7:3 (v/v). A fraction collector was used 
to monitor the separation of gangliosides in the last eluate (pro- 
panel/water). The fractions containing complex gangliosides were 
combined, evaporated, dissolved in a small volume of water and 
lyophilized. The dry material was suspended in 150 ml of 
chloroform/methanol/water, 65:25:4 (v/v), and applied to another 
silica gel column (150 g silica gel). The insoluble part of the material, 
which remained attached to the walls of the flask was dissolved in the 
smallest possible volume of water, followed by the addition of 
chloroform and methanol to make Final prcportions of chloroform, 
methanol a;,d water, 65:25:4 (v/v). The washing was applied to the 
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column. The column was run under identical conditions as the first 
one. Fractions containing gangliosides GQlb and GP were collected, 
evaporated, subjected to alkaline hydrolysis (0.2 M NaOH, 37”C, 4 
h, methanol/water, 2:l, v/v) and dialysed against distilled water for 
two days. The gangliosides were evaporated, dissolved in water and 
separated preparatively on HPTLC plates. After application of the 
material the plates were dreid carefully in a stream of warm air. The 
plates were developed in chrloroform/methanol/0.25% KCI in 2.5 M 
ammonia, 5O:JO:IO (v/v), dried in a stream of warm air, and 
developed onceagain in propanol/0.25% KCI in water, 7:3 (v/v). The 
gangliosides were visualized with a Bromophenol blue indicator. The 
band containing ganglioside GP was scraped from plates and ex- 
tracted with chloroform/methanol/water. 30:60:20 (v/v) two times, 
and with propanol/water, 7:3 (v/v) three times. The combined ex- 
tracts were evaporated and the material was dissnlved in 1 ml of 
water. 6.25 ml of methanol and 16.2 ml of chloroform were Rddcd to 
the solution and the material was applied to a silica gel column (IO g 
of silica gel suspended in chloroform/methanol, 4: 1 (v/v)). The col- 
umn was eluted with 20 ml of chloroform/methanol/0.25% KCI in 
2.5 M ammonia, 50:4D:lO (v/v), and next with propanol/water 7:3 
(v/v). The last eluate was monitored for the presence of gangliosides. 
Ganglioside GP was cc!lected, evaporated, dissolved in water (buf- 
fered with 25 FM potassium carbonate buffer, pH 8.8) and stored 
frozen. 
2.3. Analytical methods 
Sialic acid was determined according to the method of Sven- 
nerholm [IO], and sphingosine according to the modified procedure 
of Lamer and Trams [l I]. The sensitivity of GP to sialidase was tested 
twofold. In the first test, the ganglioside (I5 nmol NeuAc) was 
hydrolysed in 30 pl of 0.01 M Tris-maleate buffer (pH 6.5) containing 
2 mM CaClr. 0.25% Triton X-100 and 0.5 U/ml of Vibrio cholerae 
neuraminidase (E.C. 3.2.1.18, Behringwerke. Marburg Lahn, Ger- 
many) for 20 hat 37°C. Samples of 5 pl were put directly on HPTLC 
plates, which were developed in chloroform/methanol/O.25% KC! in 
water, 50:40: IO (v/v). The plates were stained wi:h orcinol or resor- 
cinol and evaluated visually. In the second test, the ganglioside (1-6 
pmol) was applied to the plate, which was then developed in chloro- 
form/methanol/0.25% KCI in 2.5 M ammonia and treated with 
Clostridium perfringens neuraminidase (Sigma, USA) for 5 h at 
37°C. The released ganglioside GMI was quantified with cholera tox- 
in B subunit and anti-B monoclonal antibody according to the TLC 
ELISA method previously described [It]. Fast-atom-bombardment 
mass spectrometry (FAB-MS) of the permethylated ganglioside was 
performed on a VG-ZAB mass spectrometer as previously described 
[13,14] with the exception that the material was acetylated prior to 
methylation. For acetylation the ganglioside was dissolved in 
formamide-pyridine-acetic anhydride. 10:5:4 (v/v) [15] and kept at 
room temperature overnight. The solution was next diluted 10 times 
with cold distilled water and dialysed against distilled water for two 
days. The acetylated ganglioside was evaporated, dissolved in chloro- 
form/methanol, 2:1 (v/v) and applied to a 10x 20 cm HPTLC plate, 
which was developed in chloroform/methanol/0.25~o KCI, 50:40:10 
(v/v) for approx. 10 min (solvent migration = 2.5 cm). The gel cor- 
responding to ganglioside GP (1.3 cm wide zone adjacent to the sol- 
vent front) was scraped from the plate and extracted three times with 
chloroform/methanol/water, 60:30:4.5 (v/v). After evaporation of 
solvents, the ganglioside was dissolved in 2 ml of 
chloroform/methanol/water, 60:30:4.5 (v/v), and applied to 0.5 g of 
Sephadex G-25 (fine) suspended in the same solvent. The column was 
eluted with 2.5 ml of chloroform/methanol/water, 60:30:4.5 (v/v) 
and 2.5 ml of chloroform:methanol, 2:1 (v/v). The combined eluates 
were evaporated. The material was dried in vacuum and used for 
methylation [l4]. 
3. RESULTS AND DISCUSSION 
The pentasialoganglioside fraction was obtained 
from human cerebellar cortex with a yield of 8.8 nmol 
NeuAc per g of fresh tissue. The fraction migrated on 
HPTLC plates as a homogenous band (Fig. 1) and had 
a chromatographic mobility similae to that of standard 
fish brain GPl. The relative migrations of the isolated 
GP comlpared to human brain GDlb (RoDlb), GTlb 
(&TIC) and GQlb (RGQI~) were 0.42, 0.60 and 0.66, 
respectively. The isolated gangliosides contained sialic 
acid and sphingosine in a molar ratio of 1:4.53. The 
fraction was susceptible to sialidase from Clostridium 
perfringens and Vibrio cholerae, and was converted to 
ganglioside GM 1. The formation of ganglioside GM 1 
from GP was demonstrated in a test tube reaction and 
on a plate treated with sialidase (see Section 2). The 
yield of the reaction after 5 h of incubation with the ex- 
cess of Ciostridium perfringens sialidase was 95%, as 
determined using the quantitative TLC ELISA method. 
FAR-MS of the permethylated ganglioside revealed 
major mo!ecular ions at m/z 3270 and 3298 correspon- 
ding to the composition NeuAc3*HexNAcHexr*Cer 
with Cl&O fatty acid and 4-sphingenine or 4-eico- 
sasphingenine as the long chain base. Fragment ions at 
m/z 376 (344), 737 (705) and 1098 showed the presence 
of 3 sialic acids linked together. Intense ions found at 
m/z 1186 and 1547 showed the occurrence of the ter- 
minal carbohydrate sequences NeuAc-NeuAc-Hex- 
HexNAc- and NeuAc-NeuAc-NeuAc-Hex-HexNAc-. 
Ions of equal intensity found at m/z 576 and 604 cor- 
responded to the ceramide composition C18:O fatty acid 
with 4-sphingenine and 4-eicosasphingenine (Fig. 2a 
and 2b). 
The combined structural analyses of the isolated 
pentasialoganglioside fraction suggest the following 
structures: NeuAccu2-8NeuAccr2-3GalPl-3GalNAcP 1i 
. . . . 
GM1 - 
GDIaa 
GQlbe cd.. 
- --GDlb 
s -GTtb 
2 3 
Fig. I. Thin-layer chromatography of the pentasialoganglioside 
fraction isolated from human cerebellum. The plate was developed 
successively in two solvents: (a) chloroform/methanol/O.251 KC1 in 
2.5 M ammonia, 50:40:10 (v/v); (b) propanoli0.25% KCI in water, 
7:3 (v/v), and stained with resorcinol. I. Mixture of human brain 
gangliosides (total); 2. pentasialoganglioside fraction obtained from 
human cerebellar cortex; 3. standard mixture of fish brain GPI and 
human brain GQlb; 4. standard mixture of brain gangliosides. 
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Fig. 2 (a). Fragmentation pattern obtained at positive FAB-MS of the 
permethylated pentasialoganglioside GPlc. (b) Fragmentation 
pattern obtained at positive FAB-MS of the pcrmethylated pen- 
tasialoganglioside GPlb. 
4[NeuAcor2 - 8NeuAca2 - SNeuAcar2 - 3]GalL?l- 4GlcPl- 
1Cer (ganglioside GPl c), and NeuAccr2-8NeuAca2- 
SNeuAc(r2-3Galfl1-3GalNAc,&4[NeuAccY2-8NeuAc~2- 
31 GalPI-4GlcPl-1Cer (ganglioside GPlb). 
Gangliosides containing trisialosequences in mol- 
ecules have not previously been isolated from human 
brain. Some indications of the presence in human ner- 
vous tissues of the gangliosides of the c-series come 
from immunochemical studies. The developmentally 
regulated antigen A2l35, which was reported ?o be 
structurally related to some oligosialogangliosides in-
cluding GT3 and GQlc [6,16], was found in human 
Alzheimer’s neurofibrillary tangles, human fetal 
neurons [17J, and human astrocytes [MJ. The pen- 
tasialogangliosides isolated from human cerebellar cor- 
tex are probable candidates for immune-reactive mem- 
brane components. 
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